Grandpa 20 26 20grandson 20with 20building 20blocks 20flipped
Photopharmics 20logo

PhotoPharmics

PhotoPharmics is conducting a clinical trial to establish the safety and efficacy of a non-invasive device designed to restore health to Parkinson's patients.

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Highland, UT, USA
  • Currency USD
  • Founded February 2011
  • Employees 3
  • Incorporation Type C-corp
  • Website photopharmics.com

Company Summary

Photopharmics provides specialized, non-invasive phototherapy device which allows dopamine to be assimilated by Parkinson's patients. A number of trials, including a 4-year, 130 patient study, demonstrate dramatic symptomatic improvement and continued improvement over the long term. This has never been seen in PD treatment. PPI is conducting a multi-national trial to establish the safety and efficacy of this novel therapy.

Team

  • Default avatar
    Kent Savage
    President

  • Default avatar
    Dan Adams
    Chief Science Officer

Advisors

  • Default avatar
    Tim Larsen; Squire and Company
    Accountant
    Unconfirmed
    Default avatar
    Wade Bean
    Attorney, Kunzler Law
    Unconfirmed

Previous Investors

  • Default avatar
    HDK Holdings: Daniel Adams; Kent Savage; Henry Savage; David Squire, Dr.John Hardy
    Unconfirmed